Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Robinson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The Lancet. Global Health|October 22, 2018
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation studyDimitrios Gouglas, Tung Thanh Le, Klara Henderson, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|October 11, 2021
Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 StudyKenneth S Maxwell, James M Robinson, Ines Hoffmann, et al.
The Journal of Infectious Diseases|April 12, 2012
Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutationsAnjali N Kunz, Afrin A Begum, Hong Wu, et al.
Implementation Science : IS|January 27, 2018
A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for Opioid prescribing in primary careAndrew Quanbeck, Randall T Brown, Aleksandra E Zgierska, et al.
BMC Family Practice|November 29, 2020
Increasing system-wide implementation of opioid prescribing guidelines in primary care: findings from a non-randomized stepped-wedge quality improvement projectAleksandra E Zgierska, James M Robinson, Robert P Lennon, et al.
Addiction (Abingdon, England)|January 16, 2013
Which elements of improvement collaboratives are most effective? A cluster-randomized trialDavid H Gustafson, Andrew R Quanbeck, James M Robinson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2020
Multicenter, Double-Blind, Randomized Trial of Emricasan in Hepatitis C-Treated Liver Transplant Recipients With Residual Fibrosis or CirrhosisEthan M Weinberg, Michael P Curry, Catherine T Frenette, et al.
The Oncologist|November 28, 2019
Initial Results from Mobile Low-Dose Computerized Tomographic Lung Cancer Screening Unit: Improved Outcomes for Underserved PopulationsDerek Raghavan, Mellisa Wheeler, Darcy Doege, et al.
Hepatology (Baltimore, Md.)|August 1, 2018
Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal HypertensionGuadalupe Garcia-Tsao, Michael Fuchs, Mitchell Shiffman, et al.
Journal of Hepatology|December 25, 2019
Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertensionGuadalupe Garcia-Tsao, Jaime Bosch, Zeid Kayali, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Lancet. Global Health|October 22, 2018
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation studyDimitrios Gouglas, Tung Thanh Le, Klara Henderson, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|October 11, 2021
Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 StudyKenneth S Maxwell, James M Robinson, Ines Hoffmann, et al.
The Journal of Infectious Diseases|April 12, 2012
Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutationsAnjali N Kunz, Afrin A Begum, Hong Wu, et al.
Implementation Science : IS|January 27, 2018
A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for Opioid prescribing in primary careAndrew Quanbeck, Randall T Brown, Aleksandra E Zgierska, et al.
BMC Family Practice|November 29, 2020
Increasing system-wide implementation of opioid prescribing guidelines in primary care: findings from a non-randomized stepped-wedge quality improvement projectAleksandra E Zgierska, James M Robinson, Robert P Lennon, et al.
Addiction (Abingdon, England)|January 16, 2013
Which elements of improvement collaboratives are most effective? A cluster-randomized trialDavid H Gustafson, Andrew R Quanbeck, James M Robinson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2020
Multicenter, Double-Blind, Randomized Trial of Emricasan in Hepatitis C-Treated Liver Transplant Recipients With Residual Fibrosis or CirrhosisEthan M Weinberg, Michael P Curry, Catherine T Frenette, et al.
The Oncologist|November 28, 2019
Initial Results from Mobile Low-Dose Computerized Tomographic Lung Cancer Screening Unit: Improved Outcomes for Underserved PopulationsDerek Raghavan, Mellisa Wheeler, Darcy Doege, et al.
Hepatology (Baltimore, Md.)|August 1, 2018
Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal HypertensionGuadalupe Garcia-Tsao, Michael Fuchs, Mitchell Shiffman, et al.
Journal of Hepatology|December 25, 2019
Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertensionGuadalupe Garcia-Tsao, Jaime Bosch, Zeid Kayali, et al.
Pageof 3